Prosecution Insights
Last updated: October 04, 2026

Wiggin And Dana LLP

Technology area: Biotechnology & Pharmaceuticals

19 pending office actions • 16 clients • 19 examiners • 15 art units • 0 of 19 (0%) have an AI response strategy ready

Analysis

WIGGIN AND DANA LLP operates within the Biotechnology & Pharmaceuticals sector, a field often characterized by rigorous examination standards. The firm has handled 2008 career applications, achieving a resolved allowance rate of 78.28 percent. This rate reflects the firm's ability to secure intellectual property rights in a highly technical and competitive landscape. The prosecution process at the firm involves an average of 3.26 office actions per allowance, which indicates a more iterative engagement with patent examiners compared to less complex technology areas.

With 16 pending office actions currently on the docket, the firm continues to manage its portfolio through the detailed requirements of the USPTO. The 78.28 percent allowance rate serves as a benchmark for its performance in the specialized Biotechnology & Pharmaceuticals domain. For practitioners, the average of 3.26 office actions per allowance suggests that while the path to a grant is not immediate, the firm possesses the persistence necessary to overcome technical rejections. This historical data from 2008 career applications provides a reliable indicator of the firm's capacity to navigate the life sciences patent landscape effectively.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=2008 apps, methodology: how we score firms)

78.3%
Allowance Rate
n=2008
+0.51σ
Allowance Rate (norm)
n=2008
3.3
OAs to Allowance
n=1045
-0.16σ
OAs to Allow (norm)
n=1045
997 days
Time to Allowance
n=1045
+8.8pp
Interview Lift
n=2008
22.9%
RCE Rate
n=2008
1.6%
Appeal Rate
n=2008

Rejection Performance (% of received rejections ultimately overcome)

72.8%
§101 Overcome
n=162
74.7%
§102 Overcome
n=415
79.0%
§103 Overcome
n=715
78.8%
§112 Overcome
n=520

Specialization & Scale

G06F, A61K, G06Q
Top CPC Subclasses
13%
Top-3 CPC Share
n=2008
9
Practitioners
n=2008
223.1
Apps / Practitioner
n=2008

Portfolio Summary

19
Total Pending OAs
9
Non-Final OAs
10
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (42%)
10
Medium (53%)
1
Easy (5%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (21%)
§103 only6 (32%)
§102 only1 (5%)
§112 only1 (5%)
Double-patenting + other3 (16%)
Multi-statute (no §101)4 (21%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
37% of docket
3
Information Tech
16% of docket
0
Communications
0% of docket
1
Semiconductors
5% of docket
5
Mechanical / Eng
26% of docket
3
Business / Other
16% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NELSON, FREDA ANN 1 42.8% +7.7%
BARNES JR, CARL E 1 33.3% +25.2%
HE, JIALONG 1 81.4% +32.9%
KANE, KATHARINE GRACZ 1 47.7% +45.7%
SHOMER, ISAAC 1 63.2% +30.4%
DIVELBISS, MATTHEW H 1 24.0% +25.2%
ZHANG, SHIRLEY X 1 69.8% +14.2%
DIXON, ANNETTE FREDRICKA 1 74.4% +26.0%
LAGOY, KYRA RAND 1 9.5% -11.1%
NOBLE, MARCIA STEPHENS 1 67.0% +39.9%

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18628457 PLATFORM FOR DETERMINING A COMPETENCY SCORE LAGOY, KYRA RAND 138d overdue
18357854 Stored Program Interpreter For Implementing Time-Dependent Behavior of Controlled Loads GOORAY, MARK A 87d overdue
18939439 AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM SHOMER, ISAAC 42d overdue
17672435 Microprocessor Including a Model of an Enterprise CRANDALL, RICHARD W. 2d overdue
19185744 LOCATION VERIFICATION SYSTEM AND METHOD OF VERIFYING A LOCATION OF AN ENTITY NELSON, FREDA ANN —
18881787 METHODS AND SYSTEMS FOR REAL-TIME TRANSLATION HE, JIALONG —
18899973 APPARATUS AND METHOD FOR GENERATING SYSTEM IMPROVEMENT DATA DIVELBISS, MATTHEW H —
17696635 Rocking Bioreactor with Integrated Monitoring Probe System LOPEZLIRA, ASHLEY NICOLE —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18939439 AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM SHOMER, ISAAC 42d overdue
19010621 ADAPTIVE FOOTWARE APPARATUS FOR ACCOMMODATING ANKLE-FOOT ORTHOSIS KANE, KATHARINE GRACZ 13d
19076194 APPARATUS AND METHOD FOR ADAPTIVE DATA STRUCTURE GENERATION BARNES JR, CARL E —
18881787 METHODS AND SYSTEMS FOR REAL-TIME TRANSLATION HE, JIALONG —
18899973 APPARATUS AND METHOD FOR GENERATING SYSTEM IMPROVEMENT DATA DIVELBISS, MATTHEW H —
18775568 APPARATUS AND METHOD FOR COMMUNICATIONS ASSOCIATED WITH ONE OR MORE DATA SETS ZHANG, SHIRLEY X —
18664739 PATIENT RESPIRATORY MASK WITH INTEGRATED MICROPHONE AND METHOD OF PATIENT COMMUNICATION UTILIZING THE SAME DIXON, ANNETTE FREDRICKA —
18368240 METHOD OF MANUFACTURING AUTOLOGOUS CARDIAC LINEAGE CELLS NOBLE, MARCIA STEPHENS —

Client Portfolio (16 clients)

Top Art Units

Art UnitApps
17992
21781
37321
16121
36241
24471
36851
16321
21991
16221

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19185744 LOCATION VERIFICATION SYSTEM AND METHOD OF VERIFYING A LOCATION OF AN ENTITY The Web Genie Inc. NELSON, FREDA ANN §101§103 Non-Final OA — Pending Apr 22, 2025
19076194 APPARATUS AND METHOD FOR ADAPTIVE DATA STRUCTURE GENERATION Mary Street Group Enterprises, Inc. BARNES JR, CARL E 2178 §103 Final Rejection — Pending Mar 11, 2025
18881787 METHODS AND SYSTEMS FOR REAL-TIME TRANSLATION Lucca Ventures, Inc. HE, JIALONG §102§103§112 Non-Final OA — Pending Jan 07, 2025
19010621 ADAPTIVE FOOTWARE APPARATUS FOR ACCOMMODATING ANKLE-FOOT ORTHOSIS Kompass Kicks LLC KANE, KATHARINE GRACZ 3732 §103 Final Rejection 13d Pending Jan 06, 2025
18939439 AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM Cila Therapeutics Inc. SHOMER, ISAAC 1612 §103§112 Final Rejection 42d overdue Pending Nov 06, 2024
18899973 APPARATUS AND METHOD FOR GENERATING SYSTEM IMPROVEMENT DATA The Blue Collar Success Group, LLC DIVELBISS, MATTHEW H 3624 §103 Final Rejection — Pending Sep 27, 2024
18775568 APPARATUS AND METHOD FOR COMMUNICATIONS ASSOCIATED WITH ONE OR MORE DATA SETS Dreamguard Inc. ZHANG, SHIRLEY X 2447 §102Other Final Rejection — Pending Jul 17, 2024
18664739 PATIENT RESPIRATORY MASK WITH INTEGRATED MICROPHONE AND METHOD OF PATIENT COMMUNICATION UTILIZING THE SAME Lucca Ventures, Inc. DIXON, ANNETTE FREDRICKA §102§103§112DP Non-Final OA — Pending May 15, 2024
18628457 PLATFORM FOR DETERMINING A COMPETENCY SCORE Firefly Lab, LLC LAGOY, KYRA RAND 3685 §101§103 Final Rejection 138d overdue Pending Apr 05, 2024
18368240 METHOD OF MANUFACTURING AUTOLOGOUS CARDIAC LINEAGE CELLS Regen Theranostics, Inc. NOBLE, MARCIA STEPHENS 1632 §112 Non-Final OA — Pending Sep 14, 2023
18357854 Stored Program Interpreter For Implementing Time-Dependent Behavior of Controlled Loads Astronics Advanced Electronic Systems Corp. GOORAY, MARK A 2199 §101§112 Final Rejection 87d overdue Pending Jul 24, 2023
18033194 ADMINISTRATION OF ANTIPURINERGIC COMPOSITIONS FOR TREATING NERVOUS SYSTEM DISORDERS Paxmedica, Inc. ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §102§103§112DPOther Non-Final OA — Pending Apr 21, 2023
18023686 INHALABLE THERAPEUTIC AGENTS Cila Therapeutic Inc. STEVENS, MARK V 1613 §103DP Final Rejection 88d overdue Pending Feb 27, 2023
17893279 Laser speckle imaging for live cell quantification Nirrin Technologies, Inc. GZYBOWSKI, MICHAEL STANLEY 1798 §103 Final Rejection — Pending Aug 23, 2022
17696635 Rocking Bioreactor with Integrated Monitoring Probe System Nirrin Technologies, Inc. LOPEZLIRA, ASHLEY NICOLE 1799 §102§103§112 Non-Final OA — Pending Mar 16, 2022
17672435 Microprocessor Including a Model of an Enterprise Dimitris Lyras CRANDALL, RICHARD W. 3619 §101§103§112 Non-Final OA 2d overdue Pending Feb 15, 2022
17297571 METHOD AND SENSOR FOR DETERMINING A VALUE INDICATING THE IMPEDANCE OF A SUSPENSION Hamilton Bonaduz AG SAUNCY, TONI DIAN 2863 §103 Non-Final OA 26d Pending Jan 18, 2022
17343896 DEVICE AND METHOD FOR AN INTRAOPERATIVE CANCER DETECTOR Orfactory, Inc. TOWA, RENE T 3791 §103 Final Rejection — Pending Jun 10, 2021
17337055 Disposable Cell for In Situ Monitoring Probe Nirrin Technologies, Inc. HASSAN, LIBAN M 1799 §102§103 Non-Final OA — Pending Jun 02, 2021

Managing Wiggin And Dana LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month